Chem. J. Chinese Universities ›› 2021, Vol. 42 ›› Issue (6): 1881.doi: 10.7503/cjcu20200831

• Physical Chemistry • Previous Articles     Next Articles

Cobalt Substitutions in Lanthanum Manganate Photocatalyst: First-principles and Visible-light Photocatalytic Ability Investigation

LI Yishan1,2, GUO Liang1,2(), PENG Sifan1, ZHANG Qingmao1,2, ZHANG Yuhao1,2, XU Shiqi1   

  1. 1.Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices
    2.State Key Laboratory of Optic Information Physics and Technologies,South China Normal University,Guangzhou 510006,China
  • Received:2020-11-26 Online:2021-06-10 Published:2021-06-08
  • Contact: GUO Liang E-mail:guoliangchn@163.com

Abstract:

Perovskite photocatalyst has attracted many attention due to its good stability and perfect catalytic decontamination ability. Sol-gel method can effectively and stably synthetize LaMnO3. Perovskite can effectively adjust the bandgap with substitute B site of metal and improve its catalytic performance. In this paper, The electronic and optical properties of LaMnO3 and the combination of LaMn1-xCoxO3 were simulated by the first principle method. The results showed that Co substitutions can improve the absorption ability to visible light of LaMnO3. LaMnO3 was synthetized by sol-gel method, and the stability of the structure under different pH environment was explored. The results showed that LaMnO3 was more stable under neutral or alkaline environment. The effect of LaMnO3 in different Co substitution concentration on the photocatalytic activity was studied. Among that, the results of experiment prove that the Co substitutions in LaMnO3 can improve the photocatalysis ability of LaMnO3. Compare with other proportion of Co substitutions, LaMn0.9Co0.1O3 powder showed the highest photocatalytic activity, and the degradation rate of methyl orange under visible light was 54%, which is 17% higher than that of LaMnO3.

Key words: Photocatalysis, Perovskite, First principle, Sol-gel method, Substitution

CLC Number: 

TrendMD: